- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04254237
Trocar Site Hernia After Laparoscopic Cholecystectomy, Supra Versus Infraumbilical Incision for Umbilical Trocar Entry (HOT)
Trocar Site Hernia After Laparoscopic Cholecystectomy: Randomized Clinical Trial Comparing Supra Versus Infraumbilical Incision for Umbilical Trocar Entry
Trocar site hernia is a specific complication of laparoscopic surgery. The increasingly frequent use of the laparoscopic approach has resulted in an increase in the number of hernias, mainly at the umbilical area. The appearance of a trocar site hernia can cause complications in the short and long term to the patient who may end up needing a reoperation.
In this study we want to compare the supraumbilical versus the infraumbilical location of the laparoscopy entry trocar, in terms of incisional hernia incidence.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Trocar site hernias have been considered as an underestimated problem by some surgeons. It's incidence varies in the literature between studies, which may be related to an insufficient diagnosis due to poor clinical manifestation and / or the lack of long-term follow-up of patients in some studies.
There are many risk factors that have been related to the trocar site hernia development. On one side, the patient clinical factors as the age, presence of obesity, diabetes mellitus or the smoking habits. On the other side, some risk factors related to the surgical technique have been described, as the entry technique, the size and the locations of the trocars, the fascial closure, the duration of the surgery or the infection of the surgical wound.
Regarding the location of the trocars, it seems that the middle line has more risk of incisional hernia than the lateral areas in the abdomen. However, the trocar locations out of the middle line is not always possible, especially in certain surgeries as the laparoscopic cholecystectomy where it can be necessary an expansion of the incision for removing the specimen. In the concrete case of laparoscopic cholecystectomy, the belly is usually the most popular region for placing the first trocar. However, there is not much evidence about the influence of the most popular locations of the umbilical trocar incision (supra or infraumbilical) in the development of incisional hernias.
In the middle line, the infraumbilical region presents a great ability to adapt to pressure changes, as it physiologically occurs during the pregnancy. On the other side, while the primary hernias in the supraumbilical and umbilical region are common, these are not produced in the infraumbilical region. Besides, in anatomical studies of the linea alba, a higher thickness of the fibres in the infraumbilical region has been observed, along with a different spatial arrangement, predominating the transverse fibres in the infraumbilical region and the oblique ones in the supraumbilical region. Therefore, we hypothesize whether the infraumbilical location of the trocar in the midline, theoretically a more protected region, can reduce the incidence of trocar site hernia in our patients.
The aim of this study is to compare the incidence of the Hasson trocar site hernia between the supra and infraumbilical locations a year after surgery, in high risk patients for trocar site hernia subjected to elective laparoscopic cholecystectomy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ciudad Real
-
Alcázar de San Juan, Ciudad Real, Spain, 13600
- La Mancha Centro General Hospital
-
Tomelloso, Ciudad Real, Spain, 13700
- Tomelloso General Hospital
-
Valdepeñas, Ciudad Real, Spain, 13300
- Valdepeñas General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Over 18 years old.
- Ability to understand the trial information.
- Patients with symptomatic gallstones or polyps scheduled for laparoscopic cholecystectomy.
- Elective surgery.
- One year potential follow-up.
Patients that experience one or more of the following Trocar Site Hernia risk factors:
- Over 60 years old.
- Obesity, defined as Body Mass Index (BMI) > 30 Kg/m2.
- Diabetes mellitus (DM).
- Bronchopathy: A diagnosed Chronic Obstructive Pulmonary Disease (COPD) or smokers of more than 25 cigarette packages/year.
- Accept to participate in the study and sign the informed consent.
Exclusion Criteria:
- Contraindication to conduct a laparoscopic cholecystectomy.
- Patients with previous open supramesocolic surgery.
- Patients with previous surgery that affects the umbilical region.
- Patients with umbilical hernia or history of umbilical hernia surgical correction.
- A greater than 30 cm xifo-umbilical distance.
- Extreme obesity (Body Mass Index > 50 kg/m2).
- Cancer patients or in immunosuppressive therapy.
- Connective tissue disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Intervention group
Infraumbilical Hasson trocar incision.
|
Infraumbilical Hasson trocar incision
|
|
Sham Comparator: Control group
Supraumbilical Hasson trocar incision.
|
Supraumbilical Hasson trocar incision
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trocar site hernia
Time Frame: One year
|
Number of patients presenting a trocar site hernia, at the periumbilical incision, one year after laparoscopic cholecystectomy.
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Umbilical wound complications different from Trocar Site Hernia
Time Frame: 24 hours, 7 days, 30 days, 6 months and 1 year.
|
Infection, seroma or ecchymosis at the umbilical wound
|
24 hours, 7 days, 30 days, 6 months and 1 year.
|
|
Non-umbilical wounds complications
Time Frame: 24 hours, 7 days, 30 days, 6 months and 1 year.
|
Hernia, infection, seroma, ecchymosis or evisceration at non-umbilical wounds.
|
24 hours, 7 days, 30 days, 6 months and 1 year.
|
|
Other complications
Time Frame: 24 hours, 7 days, 30 days, 6 months and 1 year.
|
Other complications not related to the surgical wound
|
24 hours, 7 days, 30 days, 6 months and 1 year.
|
|
Surgical time
Time Frame: Day 0
|
Measured in minutes from the first incision until the complete closure of the last surgical wound
|
Day 0
|
|
Conversion
Time Frame: Day 0
|
Conversion rate to open surgery (yes/no).
|
Day 0
|
|
Hospital stay
Time Frame: Day 0
|
Measured in hours from the surgery to the patient discharge.
|
Day 0
|
|
Postoperative pain
Time Frame: 24 hours and 7 days after surgery.
|
Measured using the Visual Analogue Scale (VAS), with a punctuation between 0 (no pain) and 10 (the worst conceivable pain).
|
24 hours and 7 days after surgery.
|
|
Perceived Quality of Life
Time Frame: baseline, one month and a year after surgery.
|
Measured using the SF-36 questionnaire,
|
baseline, one month and a year after surgery.
|
|
Aesthetic result
Time Frame: Six months and a year of the surgery.
|
Measured using the Visual Analogue Scale, with a punctuation between 0 (not at all satisfied) and 10 (maximum satisfaction).
|
Six months and a year of the surgery.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Antonio Morandeira-Rivas, MD PhD, La Mancha Centro General Hospital
- Study Chair: Carlos Moreno Sanz, MD PhD FACS, La Mancha Centro General Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 99-b
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholecystectomy, Laparoscopic
-
Wake Forest University Health SciencesAmerican College of SurgeonsCompletedCholecystectomy, Laparoscopic | Appendectomy, Laparoscopic | Cholecystectomy, RoboticUnited States
-
Clinical Research Centre, MalaysiaCompletedComplication Laparoscopic Cholecystectomy | Conversion Laparoscopic to Open CholecystectomyMalaysia
-
Intuitive SurgicalCompletedLaparoscopic Cholecystectomy | Robotic-assisted CholecystectomyUnited States
-
Assiut UniversityNot yet recruiting
-
IHU StrasbourgScialytics SASRecruitingCholecystectomy, LaparoscopicFrance
-
Assiut UniversityNot yet recruiting
-
Mohamed Bakr Mohamed AhmedNot yet recruitingLaparoscopic Cholecystectomy
-
Istanbul University - CerrahpasaActive, not recruitingCholecystectomy, LaparoscopicTurkey (Türkiye)
-
Ulas AdayCompletedLaparoscopic CholecystectomyTurkey (Türkiye)
-
Mansoura UniversityCompletedLaparoscopic CholecystectomyEgypt
Clinical Trials on Infraumbilical Hasson trocar incision
-
St John of God Hospital, ViennaWithdrawn
-
Assiut UniversityUnknownGynecologic DiseaseEgypt
-
Faculdade de Ciências Médicas de Minas GeraisSanta Casa de Misericórdia de Belo HorizonteRecruitingColorectal Cancer | Pain Management | Colorectal Surgery | Anesthesia | Post Operative Analgesia | Transversus Abdominis Plane (TAP) Block | Autonomic Nerve BlockBrazil